These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 2461192
61. Lipids, lipoproteins and apolipoproteins A-I and B and apolipoprotein losses in continuous ambulatory peritoneal dialysis. Steele J, Billington T, Janus E, Moran J. Atherosclerosis; 1989 Sep; 79(1):47-50. PubMed ID: 2803346 [Abstract] [Full Text] [Related]
62. Co-localization of aortic apolipoprotein B and chondroitin sulfate in an injury model of atherosclerosis. Galis ZS, Alavi MZ, Moore S. Am J Pathol; 1993 May; 142(5):1432-8. PubMed ID: 8494047 [Abstract] [Full Text] [Related]
63. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins. Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A, Duranay M, Yigitoglu R. Ren Fail; 2006 May; 28(7):567-71. PubMed ID: 17050239 [Abstract] [Full Text] [Related]
64. Expression of apolipoprotein B epitopes in lipoproteins. Relationship to conformation and function. Marcel YL, Hogue M, Weech PK, Davignon J, Milne RW. Arteriosclerosis; 1988 May; 8(6):832-44. PubMed ID: 2461695 [Abstract] [Full Text] [Related]
65. Changes in human high density lipoproteins in patients with extra-hepatic biliary obstruction. Coulhon MP, Tallet F, Yonger J, Agneray J, Raichvarg D. Clin Chim Acta; 1985 Jan 30; 145(2):163-72. PubMed ID: 3971588 [Abstract] [Full Text] [Related]
66. Antigenic differences between apo-B in native and circulating modified low-density lipoproteins. Suprun IV, Mel'nichenko AA, Yanushevskaya EV, Vlasik TN, Sobenin IA, Panasenko OM, Orekhov AN. Bull Exp Biol Med; 2004 Jul 30; 138(1):42-4. PubMed ID: 15514719 [Abstract] [Full Text] [Related]
67. Apolipoprotein(a) deposition in atherosclerotic plaques of cerebral vessels. A potential role for endothelial cells in lesion formation. Jamieson DG, Usher DC, Rader DJ, Lavi E. Am J Pathol; 1995 Dec 30; 147(6):1567-74. PubMed ID: 7495281 [Abstract] [Full Text] [Related]
68. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. Gosling J, Slaymaker S, Gu L, Tseng S, Zlot CH, Young SG, Rollins BJ, Charo IF. J Clin Invest; 1999 Mar 30; 103(6):773-8. PubMed ID: 10079097 [Abstract] [Full Text] [Related]
69. Correlation in the human aorta of APO B fractions with tissue cholesterol and collagen content. Hoff HF, Karagas M, Heideman CL, Gaubatz JW, Gotto AM. Atherosclerosis; 1979 Mar 30; 32(3):259-68. PubMed ID: 223586 [Abstract] [Full Text] [Related]
70. Apolipoprotein B localization in coronary atherosclerotic plaques from cynomolgus monkeys. Hoff HF, Bond MG. Artery; 1983 Mar 30; 12(2):104-16. PubMed ID: 6380455 [Abstract] [Full Text] [Related]
71. Polyclonal antibodies against formaldehyde-modified apolipoprotein A-I. An approach to circumventing fixation-induced loss of antigenicity in immunocytochemistry. Harrach B, Robenek H. Arteriosclerosis; 1990 Mar 30; 10(4):564-76. PubMed ID: 1695094 [Abstract] [Full Text] [Related]
72. The analysis of lipids and glycosaminoglycans of low-density lipoprotein-glycosaminoglycans complexes isolated from normal, fatty streaks and fibrous plaques of human aortic intima. Nakashima Y, Matsushima T, Takahara K, Kuroiwa A, Nakamura M. Int Angiol; 1985 Mar 30; 4(4):487-93. PubMed ID: 3834014 [Abstract] [Full Text] [Related]
73. Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding. Cohn JS, Wagner DA, Cohn SD, Millar JS, Schaefer EJ. J Clin Invest; 1990 Mar 30; 85(3):804-11. PubMed ID: 2107210 [Abstract] [Full Text] [Related]
74. Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100. Abate N, Vega GL, Grundy SM. Atherosclerosis; 1993 Dec 30; 104(1-2):159-71. PubMed ID: 8141840 [Abstract] [Full Text] [Related]
75. Transgenic rabbits expressing human apolipoprotein(a) develop more extensive atherosclerotic lesions in response to a cholesterol-rich diet. Fan J, Shimoyamada H, Sun H, Marcovina S, Honda K, Watanabe T. Arterioscler Thromb Vasc Biol; 2001 Jan 30; 21(1):88-94. PubMed ID: 11145938 [Abstract] [Full Text] [Related]
76. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo. Devlin CM, Lee SJ, Kuriakose G, Spencer C, Becker L, Grosskopf I, Ko C, Huang LS, Koschinsky ML, Cooper AD, Tabas I. Arterioscler Thromb Vasc Biol; 2005 Aug 30; 25(8):1704-10. PubMed ID: 15905467 [Abstract] [Full Text] [Related]
77. Familial hypobetalipoproteinemia caused by a mutation in the apolipoprotein B gene that results in a truncated species of apolipoprotein B (B-31). A unique mutation that helps to define the portion of the apolipoprotein B molecule required for the formation of buoyant, triglyceride-rich lipoproteins. Young SG, Hubl ST, Smith RS, Snyder SM, Terdiman JF. J Clin Invest; 1990 Mar 30; 85(3):933-42. PubMed ID: 2312735 [Abstract] [Full Text] [Related]
78. Apolipoprotein A-I and B distribution in the human cornea. Ashraf F, Cogan DG, Kruth HS. Invest Ophthalmol Vis Sci; 1993 Dec 30; 34(13):3574-8. PubMed ID: 8258515 [Abstract] [Full Text] [Related]
79. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Malek G, Li CM, Guidry C, Medeiros NE, Curcio CA. Am J Pathol; 2003 Feb 30; 162(2):413-25. PubMed ID: 12547700 [Abstract] [Full Text] [Related]
80. Apolipoprotein and lipid composition of plasma lipoproteins in neonates during the first month of life. van Biervliet JP, Rosseneu M, Bury J, Caster H, Stul MS, Lamote R. Pediatr Res; 1986 Apr 30; 20(4):324-8. PubMed ID: 3085061 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]